NEW YORK, Aug. 28, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc.ย ("Sage" or the "Company")ย (NASDAQ: SAGE). Such investors are advised to contact Robert S. Willoughby at [emailย protected]ย or 888-476-6529, ext. 7980.
Read more at prnewswire.comProvided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.